We are live on
!
Find out more
Madrigal Pharmaceuticals
MDGL
MDGL
223 hedge funds and large institutions have $3.36B invested in Madrigal Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 69 funds opening new positions, 77 increasing their positions, 55 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
158% more call options, than puts
Call options by funds: $385M | Put options by funds: $149M
103% more first-time investments, than exits
New positions opened: 69 | Existing positions closed: 34
40% more repeat investments, than reductions
Existing positions increased: 77 | Existing positions reduced: 55
18% more funds holding
Funds holding: 189 → 223 (+34)
11% more funds holding in top 10
Funds holding in top 10: 9 → 10 (+1)
1.51% less ownership
Funds ownership: 77.96% → 76.45% (-1.5%)
13% less capital invested
Capital invested by funds: $3.86B → $3.36B (-$498M)
Holders
223
Holders Change
+34
Holders Change %
+17.99%
% of All Funds
3.55%
Holding in Top 10
10
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+11.11%
% of All Funds
0.16%
New
69
Increased
77
Reduced
55
Closed
34
Calls
$385M
Puts
$149M
Net Calls
+$235M
Net Calls Change
+$402M
Top Buyers
| 1 |
Marshall Wace
London,
United Kingdom
|
+$148M |
| 2 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$107M |
| 3 |
Janus Henderson Group
London,
United Kingdom
|
+$52.6M |
| 4 |
Renaissance Technologies
New York
|
+$46.5M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$41.4M |
Top Sellers
| 1 |
State Street
Boston,
Massachusetts
|
-$202M |
| 2 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$125M |
| 3 |
LC
L1 Capital
Melbourne VIC 3000,
Australia
|
-$38.7M |
| 4 |
TCM
TCG Crossover Management
Palo Alto,
California
|
-$37.6M |
| 5 |
D.E. Shaw & Co
New York
|
-$35M |
